Dr. Gordon joined RG+A in 2017 as Senior Vice President and Head of Research. In this role, Ellen leads client service and works collaboratively with the research team to execute innovative insights and develop strategic programs across all of RG+A’s client engagements.
Ellen has over 20 years of experience in healthcare and pharmaceutical research. She brings an extensive background in designing and executing strategic research solutions that leverage custom and syndicated pharmaceutical research, utilizing both qualitative and quantitative methodologies in the US and globally. Additionally, she has conducted market research in multiple therapeutic areas, including diabetes, oncology, cardiovascular disease, and rare diseases.
Prior to joining RG+A, Ellen held senior positions at Fulcrum Research Group, ImpactRx and Market Strategies International where her responsibilities included developing and growing global pharmaceutical client practices, introducing iPad-enabled research panels in multiple countries, leading teams responsible for the execution and delivery of both custom and syndicated global market research, generating new business, and moderating physician and patient interviews.
Ellen holds a B.A. in Politics from Brandeis University, an MA in Russian Studies from Georgetown University and a Ph.D. in Political Science from the University of Michigan.